Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 9/2015

01-09-2015 | Original Article

A survey investigating the associations between self-management practices and quality of life in cancer survivors

Authors: C. Shneerson, T. Taskila, S. Greenfield, N. Gale

Published in: Supportive Care in Cancer | Issue 9/2015

Login to get access

Abstract

Purpose

To explore whether the use of self-management (SM) practices in cancer survivors impact on their health beliefs and quality of life (QoL). This is an important step in attempting to improve cancer survivors’ health pathways and their experiences of living with cancer.

Methods

A cross-sectional, postal survey study was undertaken amongst cancer survivors identified from a teaching hospital in the West Midlands, UK. The questionnaire collected demographic data from respondents and information on the number and types of SM practices—diet, exercise, complementary and alternative medicine (CAM), psychological therapies, support groups and spirituality/religion—cancer survivors used after completing their treatment. Information was also gathered regarding their QoL and internal health locus of control (HLC).

Results

A total of 445 cancer survivors responded to the survey. Multi-linear regression analysis found a positive association between SM uptake and HLC; however, none was found between SM uptake and QoL. Treatment type, ethnicity and age were significantly associated with an increased use of SM practices.

Conclusion

The study findings have implications for health care providers, who need to be aware of the links between SM uptake and treatment type, ethnicity and age, when considering how best to incorporate SM into cancer survivors’ lives. This can help cancer survivors who may benefit from using specific SM interventions that consider the socio-demographic and treatment-related factors impacting on them. Future research would benefit from assessing the motivations and benefits of cancer survivors of different ages, ethnicities and treatment modalities in terms of their decision-making about SM use.
These findings suggest that SM uptake is associated with higher internal HLC in cancer survivors. However, the influence of treatment type, ethnicity and age plays a more significant role in determining SM uptake than HLC. Cancer survivors using SM may be more motivated to utilise SM practices in relation to their age, ethnicity and treatment type, generating positive health outcomes in the process. Policy-makers should be aware of the supportive role SM interventions can play in cancer care and survivorship, with future research focussing on the perceived benefit of these SM interventions to cancer survivors.
Literature
1.
Macmillan A (2012) Living After Diagnosis, Median Cancer Survival Times, vol 2013. Macmillan Cancer Support, London
2.
Loh SY, Ong L, Ng L-L et al (2011) Qualitative Experiences of Breast Cancer Survivors on a Self-Management Intervention: 2 Year post-Intervention. ASJCP 12:1489–1495
3.
4.
Sitzia J, Hughes J, Sobrido L (1995) A Study of Patients ’ Experiences of Side-Effects Associated with Chemotherapy: Pilot Stage Report. Int J Nurs Stud 32(6):580–600PubMedCrossRef
5.
Sirois FM, Gick ML (2002) An Investigation of the Health Beliefs and Motivations of Complementary Medicine Clients. Soc Sci Med 55(6):1025–1037PubMedCrossRef
6.
Findley P, Sambamoorthi U (2009) Preventive Health Services and Lifestyle Practices in Cancer Survivors: A Population Health Investigation. J Cancer Surviv 3:43–58PubMedCrossRef
7.
Monti D, Sufian D, Peterson C (2008) Potential Role of Mind-Body Therapies in Cancer Survivorship. Am Cancer Soc 112:2607–2616
8.
9.
Shneerson C, Taskila T, Holder R et al (2014) Patterns of Self-Management Practices Undertaken by Cancer Survivors: Variations in Demographic Factors. Eur J Cancer Care. doi:10.​1111/​ecc.​12252
10.
Horneber M, Bueschel G, Dennert G et al (2012) How Many Cancer Patients Use Complementary and Alternative Medicine: A Systematic Review and Meta-Analysis. Integr Cancer Ther 11(3):187–203
11.
Hopkinson JB (2007) How People with Advanced Cancer Manage Changing Eating Habits. J Adv Nurs 59(5):454–462PubMedCrossRef
12.
Barlow J, Wright C, Sheasby J et al (2002) Self-Management Approaches for People with Chronic Conditions: A Review. Patient Educ Couns 48:177–187
13.
Shneerson C, Taskila T, Gale N et al (2013) The Effect of Complementary and Alternative Medicine on the Quality of Life of Cancer Survivors:A Systematic Review and Meta-analyses. Complement Ther Med 21:417–429
14.
15.
Osborn R, Demoncada A, Feuerstein M (2006) Psychosocial Interventions for Depression, Anxiety and Quality of Life in Cancer Survivors: Meta-analyses. Int J Psychiatry Med 36(1):13–34
16.
Hoey LM, Leropoli S, White V et al (2008) Systematic Review of Peer-Support Programs for People with Cancer. Patient Educ Couns 70(3):315–337
17.
Speck R, Courneya K, Masse L et al (2010) An Update of Controlled Physical Activity Trials in Cancer Survivors: A Systematic Review and Meta-Analysis. J Can Surviv 4:87–100
18.
Schmitz K, Holtzman J, Courneya K et al (2005) Controlled Physical Activity Trials in Cancer Survivors: A Systematic Review and Meta-analysis. Cancer Epidemiol Biomarkers Prev 14:1588–1595PubMedCrossRef
19.
Knols R, Aoronson NK, Uebelhart D et al (2005) Physical Exercise in Cancer Patients During and After Medical Treatment: A Systematic Review of Randomized and Controlled Clinical Trials. J Clin Oncol 23(16):3830–3842
20.
Cramer H, Lange S, Klose P et al (2012) Yoga for Breast Cancer Patients and Survivors: A Systematic Review and Meta-Analysis. BMC Cancer 12:412
21.
Zhang M, Liu X, Li J et al (2007) Chinese Medicinal Herbs to Treat the Side-Effects of Chemotherapy in Breast Cancer Patients. Cochrane Database of Syst Rev 18(2), CD004921
22.
Horneber M, Bueschel D, Huber R et al (2008) Mistletoe Therapy in Oncology. Cochrane Database Syst Rev 2:CD003297
23.
Kienle G, Kiene H (2010) Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies. Integr Cancer Ther 9(2):142–157PubMedCrossRef
24.
Wu T, Munro A, Guanjian L et al (2005) Chinese Medical Herbs for Chemotherapy Side-Effects in Colorectal Cancer Patients. Cochrane Database Syst Rev 2(1):1–21
25.
Wallston K, Wallston BS, DeVellis R (1978) Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Behav 6(2):160–170CrossRef
26.
Sasagawa M, Martzen M, Kelleher W et al (2008) Positive Correlation Between the Usage of Complementary and Alternative Medicine and Internal Health Locus of Control. Explorer 4(1):38–41
27.
Bishop F, Yardley L, Lewith G (2007) A Systematic Review of Beliefs Involved in the Use of Complementary and Alternative Medicine. J Health Psychol 12:851PubMedCrossRef
28.
McFadden K, Hernandez T, Ito T (2010) Attitudes Towards Complementary and Alternative Medicine Influence Its Use. Natl Inst Health 6(6)
29.
Park C, Gaffey A (2007) Relationships between Psychosocial Factors and Health Behavior Change in Cancer Survivors: An Integrative Review. Ann Behav Med 34(2):115–134PubMedCrossRef
30.
Schutzler L, Witt C (2014) Internal Health Locus of Control in Users of Complementary and Alternative Medicine: A Cross-Sectional Survey. BMC Complement Altern Med 14:320PubMedCentralPubMedCrossRef
31.
Cheung K et al (2009) EQ-5D User Guide: Basic Information on How to Use the EQ-5D. Version 2.0. EuroQol Group, Rotterdam
32.
Pickard AS, Wilke CT, Lin H-W et al (2007) Health Utilities Using the EQ-5D in Studies of Cancer. PharmacoEconomics 25(5):365–384
33.
Usta Y (2012) Importance of Social Support in Cancer Patients. Asian Pac J Cancer Prev 13:3569–3572PubMedCrossRef
34.
35.
36.
National Primary Care Research and Development Centre, Spotlight on Support for Self-Care in the NHS, in Spotlight 2007, University of Manchester: Manchester
37.
The West Midlands Knowledge and Intelligence Team, P.H.E., 2012
38.
Montserrat R, Xavier B, Mayo N (1999) Sample Size Calculations in Studies using the EuroQol 5D. Qual Life Res Int J Qual Life Asp Treat Care Rehab 8:539–549CrossRef
39.
Luo N, Chew L-H, Fong K-Y et al (2003) Do English and 5D versions Demonstrate Measurement Equivalence? An Exploratory Study. Health Qual Life Outcomes 1:7
40.
Wang H-M, Beyer M, Gensichen J et al (2008) Health Related Quality of Life Among General Practice Patients With Different Chronic Diseases in Germany: Cross Sectional Survey. BMC Public Health 8:246
41.
Corner J, Yardley J, Maher EJ et al (2009) Patterns of Complementary and Alternative Medicine Use Among Patients Undergoing Cancer Treatment. Eur J Cancer Care 18(3):271–279
42.
Barnett R (2005) Uncovering Sex and Gender Differences in Use Patterns of Self-Help and Support Groups. Prairie Women's Health Centre of Excellence, Winnipeg
43.
England TWMKAITPH (2010) National Cancer Registration Service Database. National Cancer Registration Service, England
44.
Boon H, Olatunde F, Zick S (2007) Trends in Complementary/Alternative Medicine Use by Breast Cancer Survivors: Comparing Survey Data from 1998 and 2005. BMC Women's Health 7:4
45.
Levine EG, Yoo G, Aviv C et al (2007) Ethnicity and Spirituality in Breast Cancer Survivors. J Cancer Surviv 1:212–225
46.
Benbassat J, Pilpel D, Tidhar M (2010) Patients' Preferences for Participation in Clinical Decision Making: A Review of Published Surveys. Behav Med 24(2):81–88CrossRef
47.
48.
Samarel N, Fawcett J, Tulman L (1997) Effect of Support Groups with Coaching on Adaptation to Early Stage Breast Cancer. Nurs Health 20:15–26CrossRef
49.
Fallowfield L, Hall A, Maguire GP et al (1990) Psychological Outcomes of Different Treatment Policies in Women with Early Breast Cancer Outside a Clinical Trial. BMJ 310:575–580CrossRef
50.
McPhail S, Beller E, Haines T (2012) Reference Bias: Presentation of Extreme Health States Prior to EQ-VAS Improves Health-Related Quality of Life Scores. A Randomised Cross-Over Trial. Health Qual Life Outcomes 8:146CrossRef
51.
Clayton M (2008) Management Models Pocketbook. Management Pocketbooks.
Metadata
Title
A survey investigating the associations between self-management practices and quality of life in cancer survivors
Authors
C. Shneerson
T. Taskila
S. Greenfield
N. Gale
Publication date
01-09-2015
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 9/2015
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2626-8

Other articles of this Issue 9/2015

Supportive Care in Cancer 9/2015 Go to the issue

Original Article

Meta-analysis of incidence and risk of peripheral neuropathy associated with intravenous bortezomib

Original Article

Comparison of different criteria for periodontitis case definition in head and neck cancer individuals

Original Article

Integration of complementary medicine in supportive cancer care: survey of health-care providers’ perspectives from 16 countries in the Middle East

Original Article

Statin use in cancer patients with brain metastases: a missed communication opportunity at the end of life

Commentary

Routine prescribing of gabapentin or pregabalin in supportive and palliative care: what are the comparative performances of the medications in a palliative care population?

Original Article

Is long-term cancer survivors’ quality of life comparable to that of the general population? An italian study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits